Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Reduce the Continued Risk of Venous Thromboembolism (VTE)
.
Show all posts
Showing posts with label
Reduce the Continued Risk of Venous Thromboembolism (VTE)
.
Show all posts
Thursday, November 30, 2017
FDA Approves New 10 mg Dosing for Xarelto (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
›
In continuation of my update on rivaroxaban Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) ...
›
Home
View web version
